Drug Type Small molecule drug |
Synonyms 对乙酰氨基酚/咖啡因/马来酸氯苯那敏/盐酸伪麻黄碱/盐酸甲基麻黄碱/硝酸硫胺/维生素C, 판텍에이정 |
Action agonists, antagonists, inhibitors |
Mechanism A1R agonists(Adenosine A1 receptor agonists), A2aR antagonists(Adenosine A2a receptor antagonists), Adenosine receptor antagonists + [6] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date South Korea (03 Jan 2025), |
Regulation- |
Molecular FormulaC10H15NO |
InChIKeyKWGRBVOPPLSCSI-WCBMZHEXSA-N |
CAS Registry90-82-4 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Common Cold | South Korea | 03 Jan 2025 |